MedX Health Corp
MDX.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 66.40K | 76.20K | 79.20K | 48.80K | 82.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.40K | 76.20K | 79.20K | 48.80K | 82.90K |
| Cost of Revenue | 41.40K | 36.00K | 55.50K | 47.20K | 34.00K |
| Gross Profit | 25.00K | 40.20K | 23.70K | 1.50K | 48.90K |
| SG&A Expenses | 290.00K | 487.40K | 474.00K | 374.10K | 577.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 423.50K | 614.30K | 635.70K | 511.30K | 704.50K |
| Operating Income | -357.10K | -538.10K | -556.50K | -462.50K | -621.50K |
| Income Before Tax | -508.80K | -677.00K | -687.40K | -442.10K | -1.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -508.80K | -677.00K | -687.40K | -442.10K | -1.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -508.80K | -677.00K | -687.40K | -442.10K | -1.02M |
| EBIT | -357.10K | -538.10K | -556.50K | -462.50K | -621.50K |
| EBITDA | -348.50K | -529.50K | -555.80K | -451.40K | -621.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 269.98M | 264.66M | 261.96M | 230.60M | 188.24M |
| Average Diluted Shares Outstanding | 269.98M | 264.66M | 261.96M | 230.60M | 188.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
